Lynn R Webster Selected Research

Hallucinations (Hallucination)

7/2015	The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature.
7/2006	Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lynn R Webster Research Topics

Disease

54	Pain (Aches) 01/2023 - 05/2006
24	Chronic Pain 12/2020 - 11/2005
14	Opioid-Induced Constipation 01/2023 - 01/2015
10	Respiratory Insufficiency (Respiratory Failure) 09/2022 - 03/2012
9	Opioid-Related Disorders (Opiate Addiction) 01/2018 - 03/2009
7	Neuralgia (Stump Neuralgia) 02/2012 - 07/2006
6	Nausea 01/2018 - 11/2006
6	Breakthrough Pain 09/2013 - 11/2006
5	Neoplasms (Cancer) 01/2023 - 03/2009
5	Constipation 05/2018 - 12/2006
5	Substance-Related Disorders (Drug Abuse) 01/2018 - 06/2011
5	Postherpetic Neuralgia 09/2013 - 10/2010
4	Sleep Apnea Syndromes (Sleep Apnea) 10/2015 - 05/2008
4	Sleepiness 09/2013 - 11/2006
4	Dizziness (Lightheadedness) 09/2013 - 05/2006
3	Opiate Overdose 12/2021 - 03/2012
3	Cancer Pain 01/2020 - 09/2010
3	Diarrhea 05/2018 - 05/2015
3	Morphine Dependence 01/2018 - 01/2017
3	Poisoning 11/2017 - 06/2011
3	Edema (Dropsy) 09/2013 - 04/2008
2	Hypercapnia 01/2022 - 11/2020
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 12/2017 - 12/2006
2	Hyperalgesia 10/2015 - 09/2010
2	Hallucinations (Hallucination) 07/2015 - 07/2006
2	Vomiting 05/2015 - 09/2014
2	Low Back Pain (Lumbago) 03/2015 - 12/2006
2	Infections 03/2015 - 05/2014
2	Mental Disorders (Mental Disorder) 06/2011 - 06/2011
2	Intractable Pain 05/2011 - 05/2010
2	Pruritus (Itching) 04/2008 - 12/2006
1	Obstructive Sleep Apnea 12/2020
1	Back Pain (Backache) 01/2018
1	Acute Pain 01/2018
1	Postoperative Pain 01/2018
1	Sleep Wake Disorders 10/2015
1	Psychotic Disorders (Schizoaffective Disorder) 07/2015
1	Cognitive Dysfunction 07/2015
1	Granuloma 07/2015
1	Obesity 07/2015
1	Abdominal Pain (Pain, Abdominal) 05/2015
1	Cardiac Arrhythmias (Arrythmia) 04/2015
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2015
1	Mood Disorders (Mood Disorder) 01/2015
1	Hepatitis C 05/2014

Drug/Important Bio-Agent (IBA)

56	Opioid Analgesics (Opioids)IBA 01/2023 - 11/2005
12	Morphine (MS Contin)FDA LinkGeneric 04/2019 - 04/2008
10	Oxycodone (Oxycontin)FDA LinkGeneric 09/2022 - 12/2006
8	Analgesics (Analgesic Drugs)IBA 01/2018 - 07/2006
8	Methadone (Dolophine)FDA LinkGeneric 01/2018 - 05/2008
8	Capsaicin (Zostrix)FDA Link 02/2012 - 06/2010
7	Naltrexone (ReVia)FDA LinkGeneric 04/2019 - 08/2007
7	TabletsIBA 01/2018 - 11/2006
6	Opioid Receptors (Opioid Receptor)IBA 01/2023 - 09/2014
5	Narcotic Antagonists (Opioid Antagonists)IBA 01/2023 - 03/2012
5	methylnaltrexone FDA Link 01/2023 - 01/2015
5	Fentanyl (Sublimaze)FDA LinkGeneric 12/2021 - 11/2006
5	BenzodiazepinesIBA 12/2020 - 05/2008
5	ziconotide (Prialt)FDA Link 07/2015 - 05/2006
3	Carbon DioxideIBA 01/2022 - 03/2012
3	naldemedineIBA 01/2020 - 12/2017
3	Naloxone Drug Combination Buprenorphine FDA Link 01/2016 - 01/2015
2	Buprenorphine (Subutex)FDA LinkGeneric 11/2020 - 01/2016
2	oxycodone naltrexone combinationIBA 01/2019 - 08/2007
2	Opiate AlkaloidsIBA 05/2018 - 01/2015
2	Lubiprostone FDA Link 01/2018 - 05/2015
2	Abuse-Deterrent FormulationsIBA 01/2017 - 01/2012
2	naltrexone combination morphine FDA Link 01/2016 - 09/2011
2	Naloxone (Narcan)FDA LinkGeneric 01/2015 - 03/2012
2	Anesthetics (Anesthetic Agents)IBA 01/2012 - 12/2011
2	Local AnestheticsIBA 01/2012 - 08/2011
2	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 07/2009 - 05/2006
2	OxytrexIBA 08/2007 - 12/2006
1	NitrogenIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 12/2020
1	Ethanol (Ethyl Alcohol)IBA 12/2020
1	BarbituratesIBA 12/2020
1	Central Nervous System Depressants (CNS Depressants)IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2018
1	Celecoxib (Celebrex)FDA Link 01/2018
1	LaxativesIBA 12/2017
1	Delayed-Action PreparationsIBA 01/2016
1	norbuprenorphineIBA 01/2016
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2016
1	Nonprescription Drugs (Patent Medicines)IBA 10/2015
1	Hydromorphone (Dilaudid)FDA LinkGeneric 03/2015
1	faldaprevirIBA 01/2015
1	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 09/2014
1	RNA (Ribonucleic Acid)IBA 05/2014
1	Antiviral Agents (Antivirals)IBA 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	samatasvirIBA 05/2014

Therapy/Procedure

18	Therapeutics 01/2020 - 03/2007
9	Analgesia 01/2018 - 12/2006
4	Drug Therapy (Chemotherapy) 09/2016 - 12/2008
2	Duration of Therapy 12/2011 - 01/2011
2	Pain Management 05/2011 - 07/2010